Slimbiotics GmbH, creator of the plant-based SlimBiotics probiotic for weight management and metabolic health, released findings from their clinical trial published in Nutrients. The study, conducted on 180 adults with abdominal overweight, showcased significant reductions in various markers including body fat mass, weight, and traits of metabolic syndrome in those using SlimBiotics probiotic formula and a synbiotic blend, compared to a control group. These promising results support the potential of the probiotic in enhancing weight management. Further studies are ongoing in the U.S. and globally, aiming to validate and expand upon these findings. Slimbiotics Inc. is enthusiastic about potential partnerships to offer the SlimBiotics formula globally and is in the process of securing regulatory approvals. The published trial can be accessed via the Nutrients journal.
